TEM is integrating externally developed AI pathology into its ecosystem to improve risk prediction and personalize prostate ...

The ArteraAI Prostate Test (mHSPC) is the first externally developed digital pathology algorithm being made clinically available through the Tempus ecosystem. This AI-powered test assesses a patient's ...

Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of ...

Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment ...

A new study may have found a potentially easier, less disruptive and more effective way to treat the second leading cause of ...

A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active ...

New blood test could show if prostate cancer treatment is failing - The discovery could lead to personalised treatments for ...

A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths ...

A new study suggests that prostate cancer screening could reduce deaths by 13 per cent, as cancer experts in the UK assess ...

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...

The newly developed urine test helps identify which prostate cancer patients need a biopsy and which can safely skip the ...

Prostate cancer is one of the top diagnoses for men with cancer, but early stages are tough to detect. “You know, maybe some ...